LEVIMUNE

Details for Australian Trade Mark No. 1038491 (hide)

Owner Biogen Idec MA Inc.

Convention US 23 JULY 2004 76/603890

Service Freehills

Various Convention prority claimed: 23 July 2004, United States of America, No. 76/603890 in respect of PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF DERMATOLOGICAL DISORDERS, ANTOIMMUNE DISORDERS, NEUROLOGICAL DISORDERS, PSORIASIS, M U L T I P L E S C

Filing Date 20 January 2005

Classes

Class 5 Pharmaceutical products and pharmaceutical preparations; pharmaceutical preparations for use in the treatment of dermatological disorders, antoimmune disorders, neurological disorders, psoriasis, multiple sclerosis, Crohn's Disease, transplant rejection (host-vs-graft or graft-vs-host reaction), and mitochondrial diseases

Event Publications

10 February 2005 Application filed

10 February 2005 Application Accepted

9 June 2005 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1038492

1038490-BALAVEX